EP0227799A1 - Allyl isothiocyanate and use thereof to inhibit hair loss - Google Patents

Allyl isothiocyanate and use thereof to inhibit hair loss

Info

Publication number
EP0227799A1
EP0227799A1 EP86904525A EP86904525A EP0227799A1 EP 0227799 A1 EP0227799 A1 EP 0227799A1 EP 86904525 A EP86904525 A EP 86904525A EP 86904525 A EP86904525 A EP 86904525A EP 0227799 A1 EP0227799 A1 EP 0227799A1
Authority
EP
European Patent Office
Prior art keywords
allyl isothiocyanate
composition
hair loss
weight
aitc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86904525A
Other languages
German (de)
French (fr)
Other versions
EP0227799A4 (en
Inventor
Laszlo L. Darko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARMACON Inc
Original Assignee
FARMACON Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMACON Inc filed Critical FARMACON Inc
Publication of EP0227799A1 publication Critical patent/EP0227799A1/en
Publication of EP0227799A4 publication Critical patent/EP0227799A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • This application is concerned with pharmaceutical compositions allyl isothiocyanate (AITC) , and the use of such compositions of AITC itself to inhibit hair loss from the human scalp.
  • AITC allyl isothiocyanate
  • Allyl isothiocyanate is a known compound. It may be prepared by reaction between allyl iodide and potassium thiocyanate as described by Duliere J. Pharm. Belg. 2 j _ 981 (1920).
  • AITC topical application of AITC to the human scalp, preferably in a pharmaceutically acceptable carrier will assist in the prevention of hair loss.
  • the AITC may be applied, generally by massage, in any of a variety of compositions including liquids, and viscous bases such as creams, lotions, emollients, and other compositions generally employed for topical application.
  • Useful compositions will contain from about 0.01% to 5%, preferably 0.1% to 2% by weight based on the total weight of the composition of the active ingredient.
  • shampoos may be considered as pharmaceutical compositions.
  • AITC may be used in dilute solution in water, but because of its low solubility in this carrier it will be generally employed in liquid compositions which are mixtures of water and a water miscible alkanol such as methyl, ethyl, propyl or isopropyl alcohol.
  • AITC may be compounded with vaseline, petrolatum, hydrocarbon waxes, vegetable oils such as safflower, almond or peanut oil, or other inert, pharmaceutically acceptable carriers.
  • the compositions may contain other active ingredients such as antiseptics, germicides or anti-dandruff compounds.
  • a liquid composition useful for inhibiting hair, loss is prepared by dissolving 0.5 ml. or AITC in 100 ml. of 70% ethanol-water.
  • An ointment composition of the invention is prepared by thoroughly mixing the following ingredients:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Isothiocyanate allylique destiné à empêcher la chute des cheveux chez l'homme.Allyl isothiocyanate intended to prevent hair loss in humans.

Description

Title: ALLYL ISOTHIOCYANATE AND USE THEREOF TO INHIBIT HAIR LOSS
This application is concerned with pharmaceutical compositions allyl isothiocyanate (AITC) , and the use of such compositions of AITC itself to inhibit hair loss from the human scalp.
Allyl isothiocyanate is a known compound. It may be prepared by reaction between allyl iodide and potassium thiocyanate as described by Duliere J. Pharm. Belg. 2j_ 981 (1920).
It has now been discovered that topical application of AITC to the human scalp, preferably in a pharmaceutically acceptable carrier will assist in the prevention of hair loss. The AITC may be applied, generally by massage, in any of a variety of compositions including liquids, and viscous bases such as creams, lotions, emollients, and other compositions generally employed for topical application. Useful compositions will contain from about 0.01% to 5%, preferably 0.1% to 2% by weight based on the total weight of the composition of the active ingredient.
One particularly convenient procedure, is to prepare a shampoo composition containing an effective amount of the active ingredient, and to utilize the shampoo for daily washing of the hair and scalp. For the purposes of this description, shampoos may be considered as pharmaceutical compositions.
SUBSTITUTE SHEET AITC may be used in dilute solution in water, but because of its low solubility in this carrier it will be generally employed in liquid compositions which are mixtures of water and a water miscible alkanol such as methyl, ethyl, propyl or isopropyl alcohol. For creams and lotions, AITC may be compounded with vaseline, petrolatum, hydrocarbon waxes, vegetable oils such as safflower, almond or peanut oil, or other inert, pharmaceutically acceptable carriers. The compositions may contain other active ingredients such as antiseptics, germicides or anti-dandruff compounds.
It has been found that direct application of AITC to the human scalp assists in the prevention of hair loss as determined by measuring newly grown hair length, diameter and cuticle by light microscopy. In one study used to determine the effectiveness of AITC, the compound was used in a 1:1 water isopropyl alcohol solution at a concentration of 0.01% by weight. It was administered to 35 different human subjects with a hair loss problem. It was found that 20 of the 35 subjects showed definite improvement. There were no toxic manifestations from the use of the AITC even after the sixty day study.
The following non-limiting examples are given by way of illustration only.
EXAMPLE I
A liquid composition useful for inhibiting hair, loss is prepared by dissolving 0.5 ml. or AITC in 100 ml. of 70% ethanol-water.
EXAMPLE II
An ointment composition of the invention is prepared by thoroughly mixing the following ingredients:
SUBSTITUTE SHEET AITC 10 mg.
WHITE PETROLATUM 510 mg.
WATER 400 mg.
METHYL PARABEN 1.0 mg. PROPYL PARABEN 0.02 mg.
MINERAL OIL 50 mg.
EXAMPLE III
Twenty-seven patients, ten male and seventeen female, ages 17-77 with hair loss were evaluated for reduction in hair loss using allyl isothiocyanate in 2:1 ethanol-water at a concentration of 1.5% by weight.
Procedure: A small amount was applied to scalp nightly and gently massaged.
Results: Evaluations were made by the patient and examiner and rates as: 0 - no change, 1+ - less hair loss, 2+ - much less hair loss and 3+ - no further hair loss.
1) Ten subjects (8 female, 2 male) used the mixture for one month. Of these, 6 were 0, 3 were 1+ and 1 was 3+. 2) Five subjects (3 female, 2 male) used the mixture for two months. Of these, 3 were 0, 1 was 1+ and 1 was 3+.
3) Four subjects (1 female, 3 male) used the mixture for three months. Of these 1 was 0, 1 was 2+ and 2 were 3+.
4) One subject (female) used the mixture for four months. This patient was 2+.
5) Three subjects (1 female, 2 male) used the mixture for five months. 1 was 2+ and 2 were 3+. 6) Four subjects (3 female, 1 male) used the mixture for six months. Of these, 1 was 0, 1 was 2+ and 2 were 3+.
SUBSTITUTE SHEET No adverse reactions were observed. One patient complained of "stinging".
Summary: 1 ) Fifteen patients used the mixture for 1-2 months. Of these, 9 were 0, 4 were 1+ and 2 were 3+.
2) Twelve patients used the mixture for 3-6 months. Of these, 2 had no change (0), 4 had moderate reduction in hair loss (2+) and 6 had no further hair loss (3+).
The results are summarized in the following table-.
TABLE
FEMALE Duration of Use (Months)
One Tvo Three Four Five Six Age Result Age Result Age Result Age Result Age Result Age Result
77 1+ 70 1+ 36 0 58 2+ 70 3 41 0
33 0 50 3+ 70 3+
45 0 32 0 70 2+
40 1+
40 0
65 0
50 0
63 3+
MALE
31 0 35 0 28 3+ 34 3+ 49 3+
50 1+ 17 0 33 2+ 25 2+ 33 3+
SUBSTITUTE SHEET

Claims

WHAT IS CLAIMED IS:
1. A pharmaceutical composition for the inhibition of hair loss from the human scalp which comprises from 0.01% to 5% by weight of allyl isothiocyanate together with a pharmaceutically acceptable carrier in ointment form.
2. A composition of Claim 1 containing from 0.1% to 2% by weight of allyl isothiocyanate.
3. A composition of Claim 1 wherein the pharmaceutical carrier is an aqueous liquid.
4. A composition of Claim 1 wherein the pharmaceutical carrier is a viscous base.
5. A method of inhibiting hair loss from the human scalp which comprises topical application of an amount of allyl isothiocyanate which is effective for that purpose.
6. A method of Claim 5 wherein the allyl isothiocyanate is applied in a liquid composition containing from 0.01% to 5% by weight based on the weight of the composition of allyl isothiocyanate.
7. A method of Claim 5 wherein the allyl isothiocyanate is applied in a viscous base containing from 0.01% to 5% by weight based on the weight of the composition of allyl isothiocyanate.
8. A method of Claim 5 wherein the allyl isothiocyanate is applied in a viscous base containing from 0.1% to 2% by weight based on the weight of the composition of allyl isothiocyanate.
SUBSTITUTE SHEET
EP19860904525 1985-06-20 1986-06-16 Allyl isothiocyanate and use thereof to inhibit hair loss. Withdrawn EP0227799A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74696585A 1985-06-20 1985-06-20
US746965 1985-06-20

Publications (2)

Publication Number Publication Date
EP0227799A1 true EP0227799A1 (en) 1987-07-08
EP0227799A4 EP0227799A4 (en) 1987-10-05

Family

ID=25003099

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860904525 Withdrawn EP0227799A4 (en) 1985-06-20 1986-06-16 Allyl isothiocyanate and use thereof to inhibit hair loss.

Country Status (3)

Country Link
EP (1) EP0227799A4 (en)
JP (1) JPS63500520A (en)
WO (1) WO1986007536A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826261B1 (en) * 2001-06-26 2005-03-25 Lmd TOPICAL COMPOSITION COMPRISING A CYTOTOXIC PRODUCT AND ITS USE IN THE TREATMENT OF ALOPECHE
CN101897691B (en) * 2009-05-31 2013-06-05 无锡杰西医药科技有限公司 Application of isothiocyanate compounds in promoting hair growth
CA3090188A1 (en) * 2018-02-02 2019-08-08 Commonwealth Scientific And Industrial Research Organisation Protecting a bioactive and/or precursor thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB473769A (en) * 1936-05-08 1937-10-20 Hans Haag Process for the production of a preparation for the destruction of vermin
GB2088714A (en) * 1980-11-26 1982-06-16 Marinello Rosolino Pharmaceutical compositions containing allyl isothiocyanate
US4440783A (en) * 1983-02-24 1984-04-03 Bernard Weiss Composition for repelling animals from garbage and the like

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No relevant documents have been disclosed. *
See also references of WO8607536A1 *

Also Published As

Publication number Publication date
WO1986007536A1 (en) 1986-12-31
EP0227799A4 (en) 1987-10-05
JPS63500520A (en) 1988-02-25

Similar Documents

Publication Publication Date Title
US5425954A (en) Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
US4607101A (en) Method of treating acne vulgaris with a composition containing carbamide peroxide
KR880000091A (en) Topical Pharmaceutical Compositions Method of Preparation and Use thereof
WO2000045801A2 (en) Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
KR900017590A (en) Acne treatment method and pharmaceutical composition thereof
US5853768A (en) Topical preparation and method for pain relief
US5674539A (en) Method of treating skin and composition
BR9713921A (en) Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
JPS6130567A (en) Method of stabilizing urea
JPH11116423A (en) System for stabilization of ascorbic acid based on phosphoric acid derivative and metabisulfite and composition including the same
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
JP3889037B2 (en) External pharmaceutical composition for local treatment of skin diseases, comprising corrinoid and synthetic oil or vegetable oil
AU624222B2 (en) Compositions containing thymopentin for topical treatment of skin disorders
JPS61183206A (en) Cell-activating agent
EP0227799A1 (en) Allyl isothiocyanate and use thereof to inhibit hair loss
KR880002518A (en) Anti-inflammatory composition
FR2363324A1 (en) AQUEOUS OR HYDROALCOOLIC STABLE SOLUTIONS OF PERFUMED ESSENCES OR OIL SOLUBLE MEDICINAL PRODUCTS
GB2204488A (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
KR950700050A (en) AGENT FOR USE AS AN ANTI-IRRITANT
JP7253328B2 (en) External pharmaceutical composition
JPH044300B2 (en)
EP0252033B1 (en) A "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) for use in therapy by topical application
CA2514560A1 (en) Composition for preventive treatment of cold sores
DE3880597D1 (en) COMPOSITION FOR EXTERNAL ADMINISTRATION CONTAINING AN ETHOXYLATE COMPOUND.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19870821

A4 Supplementary search report drawn up and despatched

Effective date: 19871005

17Q First examination report despatched

Effective date: 19890712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900504

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DARKO, LASZLO, L.